TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1AZIJN, Hilde; TIRRY, Ilse; VINGERHOETS, Johan et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 2, pp 718-727, issn 0066-4804, 10 p.Article

Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trialPOZNIAK, Anton L; MORALES-RAMIREZ, Javier; BOVEN, Katia et al.AIDS (London). 2010, Vol 24, Num 1, pp 55-65, issn 0269-9370, 11 p.Article

Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescentsKÖNIGS, Christoph; FEITERNA-SPERLING, Cornelia; SINHA, Rekha et al.AIDS (London). 2012, Vol 26, Num 4, pp 447-455, issn 0269-9370, 9 p.Article

The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringesBOVEN, Katia; STRYKER, Scott; KNIGHT, John et al.Kidney international. 2005, Vol 67, Num 6, pp 2346-2353, issn 0085-2538, 8 p.Article

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)WOHL, David A; ORKIN, Chloe; DOROANA, Manuela et al.Antiviral therapy (London). 2014, Vol 19, Num 2, pp 191-200, issn 1359-6535, 10 p.Article

Efficacy and Safety of Rilpivirine (TMC278) Versus Efavirenz at 48 Weeks in Treatment-Naive HIV-1-Infected Patients: Pooled Results From the Phase 3 Double-Blind Randomized ECHO and THRIVE TrialsCOHEN, Calvin J; MOLINA, Jean-Michel; CRAUWELS, Herta et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 1, pp 33-42, issn 1525-4135, 10 p.Article

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trialsNELSON, Mark; AMAYA, Gerardo; VANVEGGEL, Simon et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 8, pp 2020-2028, issn 0305-7453, 9 p.Article

96-Week resistance analyses of rilpivirine in treatment-naive, HIV-1-infected adults from the ECHO and THRIVE Phase III trialsRIMSKY, Laurence; VAN EYGEN, Veerle; HOOGSTOEL, Annemie et al.Antiviral therapy (London). 2013, Vol 18, Num 8, pp 967-977, issn 1359-6535, 11 p.Article

Genotypic and Phenotypic Characterization of HIV-1 Isolates Obtained From Patients on Rilpivirine Therapy Experiencing Virologic Failure in the Phase 3 ECHO and THRIVE Studies: 48-Week AnalysisRIMSKY, Laurence; VINGERHOETS, Johan; VAN EYGEN, Veerle et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 59, Num 1, pp 39-46, issn 1525-4135, 8 p.Article

Long-Term Efficacy, Safety, and Tolerability of Rilpivirine (RPV, TMC278) in HIV Type 1-Infected Antiretroviral-Naive Patients: Week 192 Results from a Phase llb Randomized TrialWILKIN, Aimee; POZNIAK, Anton L; MORALES-RAMIREZ, Javier et al.AIDS research and human retroviruses. 2012, Vol 28, Num 5, pp 437-446, issn 0889-2229, 10 p.Article

Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trialCOHEN, Calvin J; ANDRADE-VILLANUEVA, Jaime; VANVEGGEL, Simon et al.Lancet (British edition). 2011, Vol 378, Num 9787, pp 229-237, issn 0140-6736, 9 p.Article

Pre-existing mutations in the rilpivirine Phase III trials ECHO and THRIVE: prevalence and impact on virological responseVINGERHOETS, Johan; RIMSKY, Laurence; VAN EYGEN, Veerle et al.Antiviral therapy (London). 2013, Vol 18, Num 2, pp 253-256, issn 1359-6535, 4 p.Article

Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trialsCOHEN, Calvin J; MOLINA, Jean-Michel; RIMSKY, Laurence et al.AIDS (London). 2013, Vol 27, Num 6, pp 939-950, issn 0269-9370, 12 p.Article

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trialMOLINA, Jean-Michel; CAHN, Pedro; VANVEGGEL, Simon et al.Lancet (British edition). 2011, Vol 378, Num 9787, pp 238-246, issn 0140-6736, 9 p.Article

Anemia, Blood Loss, and Blood Transfusions in North American Children in the Intensive Care UnitBATEMAN, Scot T; LACROIX, Jacques; LI, H. Agnes et al.American journal of respiratory and critical care medicine. 2008, Vol 178, Num 1, pp 26-33, issn 1073-449X, 8 p.Article

Epoetin-associated pure red cell aplasia in patients with chronic kidney disease : solving the mysteryBOVEN, Katia; KNIGHT, John; BADER, Fred et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, pp iii33-iii40, issn 0931-0509, SUP3Article